APSR2026-1057

Yes
Late-Breaking
Submitted
Oral Presentation
AO03-006
 
 
https://storage.unitedwebnetwork.com/files/1285/1210893-46903-APSR -AO03-006_440280.pptx
Format: PPTX Only
 
Format: PDF Only
07. COPD
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Heamah Krishnan * Hospital Sultanah Nur Zahirah HSNZ Kuala Terengganu Malaysia
Azlina Samsudin - Hospital Sultanah Nur Zahirah HSNZ Kuala Terengganu Malaysia
Nurul Majidah Abdul Razak - Hospital Sultanah Nur Zahirah HSNZ Kuala Terengganu Malaysia
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Heamah
Krishnan
heamahkrishnan@gmail.com
+60178691008
31-40
Malaysia
Original Research
Blood Eosinophil Trajectories and Exacerbation Burden in COPD,A Malaysian Single-Centre Cohort Study
Maximum 25 words
Abstract Content
Blood eosinophils are important biomarkers in COPD and are increasingly used to guide treatment decisions. However, it remains unclear whether stable blood eosinophil trajectories correspond to eosinophilic phenotypes during exacerbations and how these classifications relate to exacerbation burden.
This retrospective cohort study included 215 patients with COPD from a Malaysian tertiary centre. Patients were classified according to stable blood eosinophil trajectories using serial eosinophil measurements into persistently high (≥300 cells/µL), indeterminate (100–299 cells/µL), and persistently low (<100 cells/µL) groups. Exacerbation phenotypes were classified as eosinophilic, non-eosinophilic, or indeterminate based on eosinophil counts obtained during exacerbation episodes. Associations between trajectory groups and exacerbation outcomes were assessed using Kruskal–Wallis tests and negative binomial regression. Concordance between stable trajectory groups and exacerbation phenotypes was evaluated using Cohen’s kappa statistic.
Among 215 patients, 80 (37.2%) were classified as persistently high, 88 (40.9%) as indeterminate, and 47 (21.9%) as persistently low trajectories. Significant differences in moderate, severe, and total exacerbation rates were observed across trajectory groups (p=0.006, p=0.012, and p=0.002, respectively). Patients with persistently high and indeterminate trajectories experienced higher total exacerbation burdens than those with persistently low trajectories [median 6.0 (IQR 2.0–14.8), 6.0 (3.3–11.8), and 3.0 (1.0–7.0), respectively]. In multivariable negative binomial regression, the indeterminate trajectory group remained independently associated with increased exacerbation rates compared with the persistently low group (adjusted IRR 1.8, 95% CI 1.05–3.23, p=0.033). Blood eosinophil trajectory groups were significantly associated with exacerbation eosinophilic phenotype (p<0.001). However, concordance between stable trajectory classification and exacerbation phenotype was only slight (κ=0.180, p<0.001).
Blood eosinophil trajectories are associated with exacerbation burden and phenotype in COPD, but show limited concordance with exacerbation-based classifications, highlighting the value of longitudinal eosinophil assessment.
 
 
 
 
 
No
Yes
https://storage.unitedwebnetwork.com/files/1285/1210893-37089-Data_400560.png
JPG or JPEG or PNG format ONLY
Chronic obstructive pulmonary disease, blood eosinophil trajectory , exacerbation phenotype
maximum 3 keywords and no abbreviations, separated by commas
None
312